KFDA announced revised drug safety information administration act

Published: 1999-01-12 11:40:00

Updated: 1999-01-12 11:40:00

The KFDA announced to revise the Drug Safety Information Administration Act on Dec. 28, removing the nomination system for specific hospitals and pharmacies as a monitoring institution of drug adverse reactions, and, instead, inducing all medical institutes including pharmacies to participate in ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK